I am currently a visiting scientist at MIT working with Dr. Scott Manalis in the Koch Institute for Integrative Cancer Research. My current research interest is engineering methods and devices to interrogate how a collection of tumor cells change their mass and mass accumulation rate in response to treatment. We utilize a high-precision microfluidic approach to weigh the tumor cells, elucidating their minute biophysical responses in a relatively short timescale. 

 

Furthermore, I am a co-founder and the Director of Engineering of Travera, which is an early-stage company developing a single-cell functional assay and a universal biophysical biomarker for personalized medicine in cancer.